Showing 231-240 of 1037 results for "".
Aesthetics Update: A Q&A With Modern Aesthetics® editors Saami Khalifian, MD, and Kay Durairaj, MD, FACS
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetics-update-a-qa-with-modern-aesthetics-editors-saami-khalifian-md-and-kay-durairaj-md-facs/29203/The world of aesthetic medicine is rapidly evolving, from next-generation polynucleotides and biostimulators to shifts in patient demands and perceptions of beauty. To discuss the latest trends in aesthetics, Practical Dermatology® turned to its sister publication, Modern Aesthetics®, and new ChiefHidradenitis Suppurativa Treatment and the Use of Ultrasound
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-treatment-and-the-use-of-ultrasound/24013/Experts highlight recent research and treatment advancements in hidradenitis suppurativa.Practice Model: Outsourcing Administrative Work
https://practicaldermatology.com/topics/practice-management/practice-model-outsourcing-administrative-work/23921/Call centers, billing—which office tasks might be more efficiently handled outside your practice?A Dermatologist’s Guide to LinkedIn Marketing
https://practicaldermatology.com/topics/practice-management/a-dermatologists-guide-to-linkedin-marketing/23830/Understanding unique features of the social network allows practices to optimize their brand engagement.Special Report: What I Did on My Summer Vacation
https://practicaldermatology.com/youngmd-connect/resident-resource-center/special-report-what-i-did-on-my-summer-vacation/23806/Spending time with kids at Camp Wonder changed the perspectives of these two residents.DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyNew in My Practice: Devices/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-devicesnew-products-1/23772/Finding Influencers to Promote Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/finding-influencers-to-promote-your-dermatology-practice/23757/Influencer marketing is not simply a form of paid advertisement; it is based on a mutually beneficial partnership.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-31/23656/New in My Practice: OTC/New Products
https://practicaldermatology.com/columns/new-products/new-in-my-practice-otcnew-products-2/23654/